雷帕霉素经eNOS依赖机制增加Wistar与自发性高血压大鼠的脑侧支灌注
该研究在Wistar和自发性高血压大鼠大脑中动脉闭塞模型中,于卒中后30分钟给予雷帕霉素,发现其可增加侧支灌注和再灌注脑血流,并通过eNOS介导的血管舒张实现;在Wistar大鼠中减少梗死体积,但在自发性高血压大鼠中2小时再灌注时未减少急性梗死体积。
要点
- 雷帕霉素增加Wistar和自发性高血压大鼠的侧支灌注及再灌注脑血流。
- 雷帕霉素通过增强eNOS活化舒张软脑膜吻合支。
- 再灌注脑血流比侧支灌注更能预测脑损伤程度。
核心结论
- 雷帕霉素在Wistar和自发性高血压大鼠中均增加侧支灌注和再灌注脑血流,似由增强eNOS活化介导。
研究设计与样本
- Wistar和自发性高血压大鼠(约14周龄,n=22和n=15)接受大脑中动脉闭塞(分别90和120分钟),卒中后30分钟给予或不给予雷帕霉素。
- 采用双位点激光多普勒测量大脑中动脉和侧支灌注区域变化,离体加压软脑膜吻合支研究反应性,组织学或TTC染色测量脑损伤。
主要发现
- Wistar大鼠中,雷帕霉素增加侧支灌注(43±17%)、增加再灌注脑血流(16±8%)并显著减少梗死体积(35±6 vs 63±8 mm3,P<0.05)。
- 雷帕霉素使软脑膜吻合支舒张80±9%,该效应被一氧化氮合酶抑制消除。
- 自发性高血压大鼠中,雷帕霉素增加侧支灌注32±25%、再灌注脑血流44±16%,但再灌注后2小时未减少急性梗死体积。
- 在Wistar和自发性高血压大鼠中,再灌注脑血流比侧支灌注更能预测脑损伤。
临床怎么用
- 雷帕霉素可能作为增加侧支血流的急性治疗,或作为溶栓或取栓的辅助治疗以改善再灌注血流。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Rapamycin is a clinically approved mammalian target of rapamycin inhibitor that has been shown to be neuroprotective in animal models of stroke. However, the mechanism of rapamycin-induced neuroprotection is still being explored. Our aims were to determine if rapamycin improved leptomeningeal collateral perfusion, to determine if this is through eNOS (endothelial nitric oxide synthase)-mediated vessel dilation and to determine if rapamycin increases immediate postreperfusion blood flow. METHODS: Wistar and spontaneously hypertensive rats (≈14 weeks old, n=22 and n=15, respectively) were subjected to ischemia by middle cerebral artery occlusion (90 and 120 minutes, respectively) with or without treatment with rapamycin at 30-minute poststroke. Changes in middle cerebral artery and collateral perfusion territories were measured by dual-site laser Doppler. Reactivity to rapamycin was studied using isolated and pressurized leptomeningeal anastomoses. Brain injury was measured histologically or with triphenyltetrazolium chloride staining. RESULTS: In Wistar rats, rapamycin increased collateral perfusion (43±17%), increased reperfusion cerebral blood flow (16±8%) and significantly reduced infarct volume (35±6 versus 63±8 mm3, P<0.05). Rapamycin dilated leptomeningeal anastomoses by 80±9%, which was abolished by nitric oxide synthase inhibition. In spontaneously hypertensive rats, rapamycin increased collateral perfusion by 32±25%, reperfusion cerebral blood flow by 44±16%, without reducing acute infarct volume 2 hours postreperfusion. Reperfusion cerebral blood flow was a stronger predictor of brain damage than collateral perfusion in both Wistar and spontaneously hypertensive rats. CONCLUSIONS: Rapamycin increased collateral perfusion and reperfusion cerebral blood flow in both Wistar and comorbid spontaneously hypertensive rats that appeared to be mediated by enhancing eNOS activation. These findings suggest that rapamycin may be an effective acute therapy for increasing collateral flow and as an adjunct therapy to thrombolysis or thrombectomy to improve reperfusion blood flow.
引用
- Beard DJ, Li Z, Schneider AM, et al. Rapamycin Induces an eNOS (Endothelial Nitric Oxide Synthase) Dependent Increase in Brain Collateral Perfusion in Wistar and Spontaneously Hypertensive Rats. Stroke. 2020. PMID: 32772681. doi:10.1161/STROKEAHA.120.029781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。